| Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence–derived peptides by CD94/NKG2 confers protection from natural … F Borrego, M Ulbrecht, EH Weiss, JE Coligan, AG Brooks The Journal of experimental medicine 187 (5), 813-818, 1998 | 837 | 1998 |
| Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells F Borrego, J Kabat, DK Kim, L Lieto, K Maasho, J Peña, R Solana, ... Molecular immunology 38 (9), 637-660, 2002 | 360 | 2002 |
| NK phenotypic markers and IL2 response in NK cells from elderly people F Borrego, MC Alonso, MD Galiani, J Carracedo, R Ramirez, B Ostos, ... Experimental gerontology 34 (2), 253-265, 1999 | 320 | 1999 |
| NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor AG Brooks, PE Posch, CJ Scorzelli, F Borrego, JE Coligan The Journal of experimental medicine 185 (4), 795-800, 1997 | 318 | 1997 |
| CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor BORREGO, ROBERTSON, RITZ, PEÑA, SOLANA Immunology 97 (1), 159-165, 1999 | 290 | 1999 |
| NK cell metabolism and tumor microenvironment I Terrén, A Orrantia, J Vitallé, O Zenarruzabeitia, F Borrego Frontiers in Immunology 10, 2278, 2019 | 266 | 2019 |
| Cutting edge: NKG2D is a costimulatory receptor for human naive CD8+ T cells K Maasho, J Opoku-Anane, AI Marusina, JE Coligan, F Borrego The Journal of Immunology 174 (8), 4480-4484, 2005 | 233 | 2005 |
| US Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma RA de Claro, K McGinn, V Kwitkowski, J Bullock, A Khandelwal, ... Clinical Cancer Research 18 (21), 5845-5849, 2012 | 232 | 2012 |
| The CD300 molecules: an emerging family of regulators of the immune system F Borrego Blood, The Journal of the American Society of Hematology 121 (11), 1951-1960, 2013 | 223 | 2013 |
| Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells AG Brooks, F Borrego, PE Posch, A Patamawenu, CJ Scorzelli, ... The Journal of Immunology 162 (1), 305-313, 1999 | 206 | 1999 |
| The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance F Borrego, M Masilamani, AI Marusina, X Tang, JE Coligan Immunologic research 35, 263-277, 2006 | 181 | 2006 |
| Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells VR Simhadri, JF Andersen, E Calvo, SC Choi, JE Coligan, F Borrego Blood, The Journal of the American Society of Hematology 119 (12), 2799-2809, 2012 | 166 | 2012 |
| IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells SJ Burgess, AI Marusina, I Pathmanathan, F Borrego, JE Coligan The Journal of Immunology 176 (3), 1490-1497, 2006 | 153 | 2006 |
| Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system™ K Maasho, A Marusina, NM Reynolds, JE Coligan, F Borrego Journal of immunological methods 284 (1-2), 133-140, 2004 | 146 | 2004 |
| The NKG2D receptor: immunobiology and clinical implications SJ Burgess, K Maasho, M Masilamani, S Narayanan, F Borrego, ... Immunologic research 40, 18-34, 2008 | 141 | 2008 |
| CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse M Masilamani, C Nguyen, J Kabat, F Borrego, JE Coligan The Journal of Immunology 177 (6), 3590-3596, 2006 | 130 | 2006 |
| Peptides isolated from HLA-Cw* 0304 confer different degrees of protection from natural killer cell-mediated lysis F Zappacosta, F Borrego, AG Brooks, KC Parker, JE Coligan Proceedings of the National Academy of Sciences 94 (12), 6313-6318, 1997 | 130 | 1997 |
| Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1 YP Park, SC Choi, P Kiesler, A Gil-Krzewska, F Borrego, J Weck, ... Blood, The Journal of the American Society of Hematology 118 (11), 3019-3027, 2011 | 128 | 2011 |
| The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition LC Sullivan, CS Clements, T Beddoe, D Johnson, HL Hoare, J Lin, ... Immunity 27 (6), 900-911, 2007 | 124 | 2007 |
| Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases F Borrego, J Peña, R Solana European journal of immunology 23 (5), 1039-1043, 1993 | 116 | 1993 |
Olatz ZenarruzabeitiaPhD, Biocruces Bizkaia Health Research InstituteVerified email at osakidetza.eus
